AAI Calls For Hard Look At Benefits Cos.' Merger
The American Antitrust Institute has urged the Federal Trade Commission to scrutinize Express Scripts Inc.'s planned acquisition of Next RX LLC, claiming the pharmacy benefits managers' merger would have dire anti-competitive...To view the full article, register now.
Already a subscriber? Click here to view full article